| PeproTech |
450-35(A) |
Recombinant murine Persephin
|
5ug |
|
|
| PeproTech |
450-12(A) |
Recombinant human Persephin
|
5ug |
|
|
| PeproTech |
130-13(A) |
Recombinant human PEDF
|
5ug |
|
|
| PeproTech |
300-10T(A) |
Recombinant human Oncostatin M (209 a.a.)
|
2ug |
|
|
| PeproTech |
400-36(A) |
Recombinant rat Oncostatin M
|
2ug |
|
|
| PeproTech |
120-35(A) |
Recombinant human Osteopontin
|
10ug |
|
|
| PeproTech |
140-04(A) |
Recombinant human PAI-1
|
2ug |
|
|
| PeproTech |
140-10(A) |
Recombinant human PAF-AH
|
5ug |
|
|
| PeproTech |
110-02T(A) |
Recombinant human p16-INK4a-TAT
|
5ug |
|
|
| PeproTech |
450-03(A) |
Recombinant human NT-3
|
2ug |
|
|
| PeproTech |
450-04(A) |
Recombinant human NT-4
|
2ug |
|
|
| PeproTech |
300-10(A) |
Recombinant human Oncostatin M (227 a.a.)
|
2ug |
|
|
| PeproTech |
110-02(A) |
Recombinant human p16-INK4a
|
5ug |
|
|
| PeproTech |
310-28(A) |
Recombinant human sOX40L
|
2ug |
|
|
| PeproTech |
130-03(A) |
Recombinant human OTOR
|
5ug |
|
|
| PeproTech |
450-14(A) |
Recombinant human Osteoprotegerin (OPG)
|
10ug |
|
|
| PeproTech |
120-21B(A) |
Recombinant human Nanog-TAT
|
5ug |
|
|
| PeproTech |
300-14(A) |
Recombinant human NAP-2 (CXCL7)
|
2ug |
|
|
| PeproTech |
300-67(A) |
Recombinant human Nesfatin-1
|
20ug |
|
|
| PeproTech |
450-36D(A) |
Recombinant human Neuritin
|
5ug |
|
|
| PeproTech |
250-25B(A) |
Recombinant murine Neuropoietin
|
5ug |
|
|
| PeproTech |
130-14(A) |
Recombinant human Neuroserpin
|
5ug |
|
|
| PeproTech |
450-11(A) |
Recombinant human Neurturin
|
5ug |
|
|
| PeproTech |
300-42(A) |
Recombinant human NP-1
|
5ug |
|
|
| PeproTech |
120-26(A) |
Recombinant human NOV
|
5ug |
|
|
| PeproTech |
250-38(A) |
Recombinant murine NOGGIN
|
5ug |
|
|
| PeproTech |
120-10C(A) |
Recombinant human NOGGIN
|
5ug |
|
|
| PeproTech |
450-18(A) |
Recombinant human NNT-1/BCSF-3
|
2ug |
|
|
| PeproTech |
450-34(A) |
Recombinant murine β-NGF
|
5ug |
|
|
| PeproTech |
450-01(A) |
Recombinant human β-NGF
|
20ug |
|
|
| PeproTech |
300-29A(A) |
Recombinant human MIP-3α (CCL20)
|
5ug |
|
|
| PeproTech |
250-27(A) |
Recombinant murine MIP-3α (CCL20)
|
5ug |
|
|
| PeproTech |
300-29B(A) |
Recombinant human MIP-3β (CCL19)
|
5ug |
|
|
| PeproTech |
250-27B(A) |
Recombinant murine MIP-3β (CCL19)
|
5ug |
|
|
| PeproTech |
300-34(A) |
Recombinant human MIP-4/PARC (CCL18)
|
2ug |
|
|
| PeproTech |
300-43(A) |
Recombinant human MIP-5 (CCL15)
|
5ug |
|
|
| PeproTech |
420-01(A) |
Recombinant human MMP-1
|
2ug |
|
|
| PeproTech |
420-02(A) |
Recombinant human MMP-2
|
2ug |
|
|
| PeproTech |
420-03(A) |
Recombinant human MMP-3
|
2ug |
|
|
| PeproTech |
150-12(A) |
Recombinant Mycoplasma Arginine Deiminase
|
5ug |
|
|
| PeproTech |
120-00(A) |
Recombinant human/murine/rat Myostatin
|
2ug |
|
|
| PeproTech |
120-21(A) |
Recombinant human Nanog
|
5ug |
|
|
| PeproTech |
120-12(A) |
Recombinant human Myostatin Propeptide
|
5ug |
|
|
| PeproTech |
300-29(A) |
Recombinant human MIP-3 (CCL23)
|
5ug |
|
|
| PeproTech |
350-03(A) |
Recombinant viral MIP-2
|
10ug |
|
|
| PeproTech |
250-15(A) |
Recombinant murine MIP-2 (CXCL2)
|
5ug |
|
|
| PeproTech |
250-12(A) |
Recombinant murine MIP-1γ (CCL9/10)
|
5ug |
|
|
| PeproTech |
400-09(A) |
Recombinant rat MIP-1β (CCL4)
|
5ug |
|
|
| PeproTech |
250-32(A) |
Recombinant murine MIP-1β (CCL4)
|
2ug |
|
|
| PeproTech |
300-09(A) |
Recombinant human MIP-1β (CCL4)
|
2ug |
|
|